Clinical trials
Bacteremia clinical trials
Below are recruiting bacteremia clinical trials, each written for real people, not researchers. We’re tracking 42 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07376889RecruitingPhase 4
Combination antibiotics for blood staph infection
This study tests different combinations of antibiotics to treat a staph infection in the blood. If you're in an Intermountain hospital with this infection, the trial may help doctors find the most effective treatment for you.
Brighton, ColoradoAges 18 years+ - NCT06650501RecruitingPhase 4
Comparing two blood thinners for staph bloodstream infections
This study compares two types of blood thinners (dabigatran vs. a common Xa inhibitor like apixaban) in people with a staph infection in their blood. The goal is to see which is safer and works better.
St. John's, Newfoundland and LabradorAges 18 years+ - NCT06637332RecruitingPhase 4
Comparing two drugs for MRSA bloodstream infections
This trial compares two antibiotics, vancomycin and daptomycin, to see which works better for treating MRSA bacteria in the blood. Patients are randomly assigned to one of the drugs and will be monitored closely for results and side effects.
Blacktown, New South WalesAges 18 years+ - NCT04291768RecruitingPhase 4
Shorter 5-day antibiotics for certain gram-negative bloodstream infections
This trial tests whether people with a specific type of bloodstream infection caused by gram-negative bacteria can safely take antibiotics for only 5 days instead of longer. It may help by reducing antibiotic exposure if your infection source is controlled quickly.
AalborgAges 18 years+ - NCT07388381Recruiting
Blood infection and vein clots from long IV catheters
This study looks at how often people with a blood infection from a PICC or midline catheter also get a blood clot in the vein of their arm. The goal is to learn more about this problem so doctors can better prevent and treat it.
Nice, CHU de NiceAges 18 years+ - NCT07183410Recruiting
Blood culture from arterial lines in intensive care
This study looks at whether taking blood cultures from an arterial line (a small tube in an artery) gives more accurate results and is less likely to have false positives compared to how blood is usually drawn. It may help improve how infections are detected in ICU patients.
Kfar SabaAges 18–99 - NCT07148960Enrolling by invitationPhase 4
Early dual antibiotics for staph bloodstream infections
This trial tests whether giving two antibiotics early, instead of the usual one, improves recovery for people with a staph bloodstream infection (a serious bacterial infection in the blood). If you qualify, participation will involve close monitoring and follow-up care.
Morgantown, West VirginiaAges 18 years+ - NCT07126106Recruiting
Testing a computer program to find sepsis earlier in the ICU
This study tests a new computer program that helps doctors find serious infections (sepsis and bacteremia) earlier in ICU patients. If you join, the program will analyze your health data to see if it can better predict these infections, which could help you get faster treatment.
Seyrantepe, IstanbulAges 18 years+ - NCT04886284RecruitingPhase 2
Cefazolin plus ertapenem for MSSA bloodstream infection
This Phase 2 study tests whether adding ertapenem to cefazolin can improve treatment of staphylococcus (“S. aureus”) bloodstream infection that is likely methicillin-susceptible (MSSA). It aims to start the right antibiotics quickly, before MRSA status is fully confirmed, using early testing and a treatment plan guided by infectious-disease specialists.
Calgary, AlbertaAges 18–100 - NCT00901602Recruiting
Study of invasive pneumococcal infections in Lebanon
This study collects laboratory samples from patients with invasive pneumococcal infections to learn about the germ and where it spreads. It may help doctors and public health teams track infection patterns and improve prevention and treatment planning.
BeirutAges 1 day+ - NCT05224401RecruitingPhase 3
Oral antibiotic step-down for ESBL bladder infections
This Phase 3 trial tests whether switching from short-term IV antibiotics to an oral antibiotic combo is safe and effective for ESBL urine infections. It may help you avoid staying on IV antibiotics as long, if your bacteria are the right match.
HelsingborgAges 18–130 - NCT07859852Recruiting
Blood test for bloodstream infections
This study tests a new blood test that may find bloodstream infections faster and more accurately than standard methods. It could help doctors start the right treatment sooner.
Orange, CaliforniaAges Any age - NCT02979951Recruiting
IV fosfomycin for serious bacterial infections
This trial studies whether IV (through a vein) fosfomycin can treat severe bacterial infections in adults. It may help people whose infection is covered by the standard fosfomycin use and who need hospital-level care.
Hall in TirolAges 18 years+ - NCT07491419Recruiting
Test to Speed Up Antibiotic Choice for Blood Infections
This trial checks if a faster test to find the best antibiotic for a bloodstream infection can improve treatment and outcomes. If you have a confirmed bloodstream infection, you may be able to join.
Rozzano, MilanAges 18 years+ - NCT07408544Recruiting
Faster infection test for bloodstream infections
This trial tests a rapid diagnostic method that identifies the bacteria in your blood more quickly than standard tests. If it works, doctors can pick the right antibiotic sooner.
Istanbul, BagcılarAges 18 years+ - NCT07343167Recruiting
Study of factors linked to death in certain strep blood infections
This study looks at people who had a bloodstream infection caused by a specific group of streptococcus bacteria (Streptococcus anginosus group). The goal is to understand what factors might be linked to death in these infections.
StrasbourgAges 18 years+ - NCT07313865Recruiting
Blood infection study to understand heart valve infections
This study collects blood samples and medical information from patients with certain bloodstream infections to better understand why some develop a heart valve infection. The goal is to find out why some people get this complication and how to predict it.
Clermont-Ferrand, FranceAges 18 years+ - NCT07299539Recruiting
Treatment study for enterococcus faecalis bloodstream infection
This trial looks at how well certain penicillin-type antibiotics work for treating a bloodstream infection caused by a bacterium called Enterococcus faecalis. It may help doctors know which treatment is best for patients with this infection.
StrasbourgAges 18 years+ - NCT07240077RecruitingPhase 4
Adding levofloxacin to beta-lactam for streptococcal blood infection
This trial tests whether adding levofloxacin to standard beta-lactam antibiotics works better for treating streptococcal blood infections. It may help if you have a confirmed strep infection in your blood and are already on or about to start beta-lactam therapy.
BangkokAges 18 years+ - NCT05117398RecruitingPhase 3
Dalbavancin vs standard antibiotics for catheter bloodstream infection
This trial tests whether dalbavancin (an antibiotic given as a dose or doses) works as well as standard antibiotics to treat bloodstream infections related to a removed IV catheter caused by Staphylococcus aureus. It may help reduce treatment time and dosing complexity if you qualify.
GarchesAges 18 years+ - NCT07134751Recruiting
Febrile Infants Swedish Study
This study looks at babies 60 days or younger who have a fever of 100.4°F or higher. It aims to better understand and manage fevers in young infants.
GothenburgAges Up to 2 months - NCT06168474Recruiting
Simplified consent process for staph infection trial
This study tests a simpler way to explain the trial and get your consent. If you have a staph bloodstream infection, you may be able to join and help improve how consent is done for future patients.
Calgary, AlbertaAges Any age - NCT06966284Recruiting
Study Comparing Two Antibiotics for Resistant Infections
This study looks at two strong antibiotics, polymyxin B and colistin, given through a vein to treat serious infections like pneumonia or blood infections caused by bacteria that are resistant to many other antibiotics. The goal is to see how well they work and how safe they are.
TaipeiAges 18 years+ - NCT06958835Recruiting
Linezolid plus standard care for staph bloodstream infections
This trial tests whether adding linezolid, an antibiotic that stops bacteria from making proteins, to usual care works better for treating Staphylococcus aureus bloodstream infections. You may be eligible if you have this infection and are hospitalized.
Aarau, Canton of AargauAges 18 years+
Hear when a new Bacteremia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for bacteremia?
- Yes. Clin2 currently lists 42 recruiting bacteremia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a bacteremia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a bacteremia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.